We are live on ! Find out more
CO

Global Cord Blood Corporation

Delisted

CO was delisted on the 23rd of September, 2022.

32 hedge funds and large institutions have $39.6M invested in Global Cord Blood Corporation in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

680% more call options, than puts

Call options by funds: $788K | Put options by funds: $101K

57% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 7

47% more capital invested

Capital invested by funds: $26.8M → $39.6M (+$12.7M)

14% more funds holding

Funds holding: 2832 (+4)

33% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 9

Holders
32
Holders Change
+4
Holders Change %
+14.29%
% of All Funds
0.56%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
6
Reduced
9
Closed
7
Calls
$788K
Puts
$101K
Net Calls
+$687K
Net Calls Change
+$723K
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$16.2M -$1.48M -340,100 -9%
OMC
2
Oasis Management Company
Cayman Islands
$8.26M +$4.76M +1,096,902 +151%
Man Group
3
Man Group
United Kingdom
$6.25M +$3.29M +758,693 +122%
QOP
4
Quinn Opportunity Partners
Virginia
$1.47M +$260K +60,000 +23%
BCM
5
BlueCrest Capital Management
Jersey
$1.04M +$998K +230,000 New
SG Americas Securities
6
SG Americas Securities
New York
$916K +$877K +202,213 New
Morgan Stanley
7
Morgan Stanley
New York
$790K +$12.9K +2,963 +2%
Natixis Advisors
8
Natixis Advisors
Massachusetts
$774K +$741K +170,889 New
Deutsche Bank
9
Deutsche Bank
Germany
$633K +$606K +139,636 New
Arrowstreet Capital
10
Arrowstreet Capital
Massachusetts
$544K -$1.25M -289,294 -71%
Qube Research & Technologies (QRT)
11
Qube Research & Technologies (QRT)
United Kingdom
$428K +$410K +94,431 New
Barclays
12
Barclays
United Kingdom
$426K +$408K +94,132 New
Bank of America
13
Bank of America
North Carolina
$389K
PPA
14
Parametric Portfolio Associates
Washington
$280K -$115K -26,443 -30%
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$181K -$13K -2,990 -7%
HF
16
HRT Financial
New York
$176K +$169K +39,064 New
Acadian Asset Management
17
Acadian Asset Management
Massachusetts
$168K +$161K +37,081 New
SSA
18
Schonfeld Strategic Advisors
New York
$124K -$23.9K -5,500 -17%
CCIA
19
Campbell & Co Investment Adviser
Maryland
$124K +$119K +27,400 New
JP Morgan Chase
20
JP Morgan Chase
New York
$87K +$69.4K +16,006 +515%
American Century Companies
21
American Century Companies
Missouri
$69K +$66.5K +15,332 New
MFW
22
Mosaic Family Wealth
Missouri
$56K
Northern Trust
23
Northern Trust
Illinois
$52K -$31.2K -7,202 -39%
MGIA
24
Moneta Group Investment Advisors
Missouri
$50K -$56 -13 -0.1%
FCI
25
Financial Counselors Inc
Kansas
$46K

CO Hedge Fund Activity: Q1 2021 in Review

32 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q1 2021, worth a combined $39.6M — up 47% from $26.8M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new CO positions and 7 closed out — a net gain of 4 holders — while 6 added to existing stakes and 9 trimmed.

The largest buyer was Oasis Management Company, adding an estimated $4.76M. The largest seller was Rock Springs Capital Management, exiting entirely with an estimated $2.88M sold.

  • 32 institutional investors held Global Cord Blood Corporation (CO) as of Q1 2021, up from 28 in Q4 2020.
  • Funds reported $39.6M of Global Cord Blood Corporation stock for Q1 2021, up 47% quarter-over-quarter.
  • 11 funds opened new Global Cord Blood Corporation positions in Q1 2021 and 7 closed out, a net change of +4 holders.
  • The largest Global Cord Blood Corporation buyer in Q1 2021 was Oasis Management Company, an estimated $4.76M added.
  • The largest Global Cord Blood Corporation seller in Q1 2021 was Rock Springs Capital Management, an estimated $2.88M sold.

Based on aggregated 13F filings for Q1 2021.